SIOPEN

  • International Society of Paediatric Oncology Europe Neuroblastoma

Molecular monitoring

PCR.jpg

A PCR machine is loaded with samples

 

The Molecular Monitoring committee is chaired by Dr Sue Burchill. 

Molecular monitoring involves techniques to detect neuroblastoma cells at a very low level, typically at levels too low to easily be able to detect the presence of neuroblastoma cells by looking at a sample using a microscope. The technique uses a process known as PCR to detect specific DNA (genetic) signals from neuroblastoma cells in samples of blood or bone marrow. In this way it is possible to determine whether or not even very low levels of neuroblastoma cells remain. It is hoped that in the future this technique will make it possible to identify patients at higher risk of relapse who might benefit from additional treatment.

 

SIOPEN meetings

Forthcoming meetings:

Berlin (Germany) AGM

25-27 October 2017 

click for more information

SIOPEN

SIOPEN Verein zur Foderung der Neuroblastomforschung is an Association registered in Austria and recognised as a non-profit organisation according to the Austrian Federal Tax Code (Bundesabgabenordnung BAO). Registration number ZVR 396592912. The SIOPEN Association was officially established on 20 January 2009.

This website makes use of stock photography and images do not represent particular individuals treated by SIOPEN institutions.